GSK Ties Up with Tokyo University Venture for New Drug Candidate Exploration

GlaxoSmithKline Group (GSK) and PeptiDream Inc. (Meguro-ku, Tokyo), a venture company originating from the University of Tokyo, announced on September 26 that they concluded a collaboration and license agreement regarding the exploration of new drugs on September 14. Under the...read more